A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...
Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
The gut microbiome has been shown to influence tumor growth and contribute to therapeutic resistance. Scientists have ...
BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment Glutamine silences BATF2 and leads to a weakened immune response ...
News-Medical.Net on MSN
UVA researcher wins $700,000 for promising ovarian cancer research
Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has ...
2don MSN
Immune sabotage: How a Vitamin A byproduct compromises the body's normal anti-cancer response
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...
The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback